Silo Pharma
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
677 N Washington Blvd, Sarasota, Florida...Phone Number
(718) 400-9031Website
www.silopharma.comRevenue
<$5 MillionStock Symbol
SILOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Silo Pharma
Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing novel therapies that are conventional drugs and psychedelic formulations.Explore more
Silo Pharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Silo Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Silo Pharma is spiking on competitors!
Click to see if Silo Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Silo Pharma launches new products
Check if Silo Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Silo Pharma has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Silo Pharma
Earning: See what the market has to say on Silo Pharma recently announced quarterly report
Silo Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Silo Pharma
Find more new buyers
Compare Similar Companies to Silo Pharma
Compare insights from companies similar to Silo Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Silo Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Silo Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Silo Pharma.
Silo Pharma financials insights
Gather financial insights about Silo Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$4.3M
Silo Pharma Tech Stack
A closer look at the technologies used by Silo Pharma
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Research & Development, Intellectual Property, Legal Affairs, Medical Research
Project
Intellectual Property
Partnership
Partnership, Research & Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Partnership
Research & Development
Silo Pharma News & Media
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
SARASOTA, FLA., June 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it received confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC informing the Company that, as of June 17, 2026, it has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). Silo’s comSilo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicinesSilo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatmentSilo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
Launch of Dedicated AI Subsidiary Positions Company for New Revenue Streams While Advancing PTSD Program Toward Phase 1
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Silo Pharma
Sign Up For FreeTo access detailed company insights
Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing novel therapies that are conventional drugs and psychedelic formula... Read More
